1-19 of 19
Jia Li, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tet2 Inactivation Enhances the Anti-Tumor Activity of Tumor-Infiltrating Lymphocytes (TILs) to Curtail Melanoma Growth

Minjung Lee, PhD, Jianfang Li, PhD, Shaohai Fang, MS, Joanna Zhang, Anh Tran Tram Vo, Wei Han, MS, Hongxiang Zeng, PhD, Sevinj Isgandarova, Margarita Martinez Moczygemba, PhD, Yubin Zhou, PhD, Jia Li, PhD, Deqiang Sun, PhD, Yun Huang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27.
https://doi.org/10.1182/blood-2020-137242
Published: 2020
Journal Articles

ZRSR1 Cooperates with ZRSR2 in Regulating Splicing of U12-Type Introns in Murine Hematopoietic Cells

Zeya Cao, Vikas Madan, PhD, Weoi Woon Teoh, Pushkar Dakle, Lin Han, PhD, Pavithra Shyamsunder, Siqin Zhou, Jia Li, PhD, Hazimah Binte Mohd Nordin, Shi Jizhong, Yu Shuizhou, Henry Yang, PhD, Md Zakir Hossain, Wee-Joo Chng, MBBS, PhD FRCPath, FRCP, H. Phillip Koeffler, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22.
https://doi.org/10.1182/blood-2020-136071
Published: 2020
Journal Articles

Highly-Sensitive DNA Hydroxymethylation Analysis in Myelodysplastic Syndromes (MDS)

Jia Li, PhD, Yue Wei, PhD, Minjung Lee, Hui Yang, MD PhD, Caleb Class, PhD, Stefan Siwko, Yubin Zhou, PhD, Deqiang Sun, PhD, Guillermo Garcia-Manero, MD, Yun Huang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17.
https://doi.org/10.1182/blood-2020-137733
Published: 2020
Journal Articles

Male-Biased Spliceosome Mutations in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Impair pDC Activation and Apoptosis

Katsuhiro Togami, MDPhD, Sun Sook Chung, PhD, Vikas Madan, PhD, Christopher M. Kenyon, BS, Lucia Cabal-Hierro, PhD, Justin Taylor, MD, Sunhee Kim, MD, Gabriel K Griffin, MD, Mahmoud Ghandi, Jia Li, PhD, Yvonne Y. Li, PhD, Fanny Angelot-Delletre, PhD, Sabeha Biichle, Michael Seiler, Silvia Buonamici, PhD, Scott B Lovitch, MDPhD, Abner Louissaint, Jr., MD PhD, Elizabeth A Morgan, MD, Fabrice Jardin, MD PhD, Pier Paolo Piccaluga, MD PhD, David M. Weinstock, MD, Peter S. Hammerman, MD PhD, Henry Yang, PhD, Marina Konopleva, MD PhD, Naveen Pemmaraju, MD, Francine Garnache-Ottou, PhD, Omar Abdel-Wahab, MD, H. Phillip Koeffler, MD, Andrew A Lane, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-137727
Published: 2020
Journal Articles

Survival Patterns in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: Treatment Trajectories and Responses after the First Relapse

Ahmad S Halwani, MD, Hsu-Chih Chien, PhD MSc, Deborah Kay Morreall, BS, Vikas Patil, MS, Kelli M Rasmussen, MS, Catherine Li, PhD, Zachary R Burningham, PhD, Anthony S Masaquel, PhD MPH, Mary Halloran, PharmD, BCPS, Elisha Delong-Sieg, PharmD, Mathias Schulz, MD MBA, Jia Li, PhD, Brian C Sauer, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1622.
https://doi.org/10.1182/blood-2019-127719
Published: 2019
Journal Articles

Comprehensive DNA 5-Hydroxymethylation Landscapes in Myelodysplastic Syndromes (MDS)

Jia Li, PhD, Yue Wei, PhD, Minjung Lee, MS, Caleb Class, PhD, Hui Yang, PhDMD, Deqiang Sun, PhD, Guillermo Garcia-Manero, MD, Yun Huang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2996.
https://doi.org/10.1182/blood-2019-128599
Published: 2019
Journal Articles

Improvements in Health-Related Quality of Life and Symptoms in Patients with Previously Untreated Chronic Lymphocytic Leukemia: Final Results from the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine

Alexey Danilov, MD PhD, Habte A Yimer, MD, Michael Boxer, MD, John M Burke, MD, Sunil Babu, MD, Jia Li, PhD, Yong Mun, PhD, Peter C Trask, PhD MPH, Anthony S Masaquel, PhD MPH, Jeff P. Sharman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3491.
https://doi.org/10.1182/blood-2019-123630
Published: 2019
Journal Articles

Final Results from the Multicenter, Open-Label, Phase II GIBB Study of Obinutuzumab+Bendamustine in Previously Untreated Patients with Chronic Lymphocytic Leukemia

Jeff P. Sharman, MD, John M Burke, MD, Habte A Yimer, MD, Michael A. Boxer, MD, Sunil Babu, MD, Jia Li, PhD, Yong Mun, PhD, Alexey Danilov, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4317.
https://doi.org/10.1182/blood-2019-122482
Published: 2019
Journal Articles

A Combination Strategy Targeting Enhancer Plasticity Exerts Synergistic Lethality Against Beti-Resistant Leukemia Cells

Lei Guo, PhD, Jia Li, PhD, Hongxiang Zeng, PhD, Anna Guzman, Tingting Li, MD, Minjung Lee, MS, Yubin Zhou, PhD, Clifford Stephan, Peter J.A Davies, Margaret Goodell, PhD, Deqiang Sun, PhD, Mark A. Dawson, PhD MBBS, Yun Huang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5053.
https://doi.org/10.1182/blood-2019-130586
Published: 2019
Journal Articles

Antibiotics Treatment Ameliorates TET2 Loss of Function Associated Hematological Malignancies

Hongxiang Zeng, PhD, Hailan He, MS, Jia Li, PhD, Wei Han, MS, Anna Guzman, Deqiang Sun, PhD, Katherine Y. King, MD PhD, Margaret A. Goodell, PhD, Yun Huang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2610.
https://doi.org/10.1182/blood-2018-99-116424
Published: 2018
Journal Articles

Tet2 Deficiency in Macrophages Undermines Heart Repair after Infarction

Shaohai Fang, MS, Yang Xiao, PhD, Jia Li, PhD, Tingting Li, MD, Hongxiang Zeng, PhD, Wei Han, MS, Yubin Zhou, PhD, Deqiang Sun, PhD, James M. Martin, MD, Yun Huang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2394.
https://doi.org/10.1182/blood-2018-99-115358
Published: 2018
Journal Articles

The Lysine Acetyltransferase Tip60 Is Required for Hematopoietic Stem Cell Maintenance

Akihiko Numata, MD, Hui Si Kwok, PhD, Qi-Ling Zhou, Jia Li, PhD, Rebecca Hannah, Jihye Park, PhD, Vladimir Espinosa Angarcia, PhD, Berthold Gottgens, Henry Yang, PhD, John Lough, PhD, Deepak Bararia, PhD, Daniel G. Tenen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2554.
https://doi.org/10.1182/blood-2018-99-118316
Published: 2018
Journal Articles

Treatment Practices and Outcomes in Older Adults with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the Veterans Health Administration

Ahmad S Halwani, MD, Kelli M Rasmussen, MS, Vikas Patil, MS, Catherine Li, PhD, Christina Young, MA, Zachary Burningham, PhD, Mathias Schulz, MD MBA, Jia Li, PhD, Anthony Masaquel, PhD MPH, Mary Halloran, PharmD, Elisha Delong-Sieg, PharmD, Brian C Sauer, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4205.
https://doi.org/10.1182/blood-2018-99-116695
Published: 2018
Journal Articles

Synthetic Lethality of Combinatory Inhibition of BET and CDK7 in BET(i) Resistant Leukemia Cells

Lei Guo, PhD, Jia Li, PhD, Shaohai Fang, MS, Minjung Lee, MS, Hongxiang Zeng, PhD, Tingting Li, MD, Wei Han, MS, Deqiang Sun, PhD, Yun Huang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1354.
https://doi.org/10.1182/blood-2018-99-116634
Published: 2018
Journal Articles

Disruption of TET2 Dioxygenase Enhances Antitumor Efficiency in CD8+ Tumor Infiltrating Lymphocytes

Minjung Lee, MS, Hongxiang Zeng, PhD, Jia Li, PhD, Wei Han, MS, Deqiang Sun, PhD, Yun Huang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 860.
https://doi.org/10.1182/blood-2018-99-115405
Published: 2018
Journal Articles

Improvements in Health-Related Quality of Life and Symptoms in Patients with Previously Untreated Chronic Lymphocytic Leukemia: Results from the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine

Jeffrey P. Sharman, MD, Habte Yimer, MD, Michael Boxer, MD, Nicholas Di Bella, Sunil Babu, Jia Li, PhD, Yong Mun, Peter Trask, Anthony Masaquel, MPH, PhD, Carolina M Reyes, PhD, Alexey Danilov, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 683.
https://doi.org/10.1182/blood.V130.Suppl_1.683.683
Published: 2017
Journal Articles

Is Obinutuzumab Plus Chemotherapy Followed By Obinutuzumab Monotherapy for Previously Untreated Follicular Lymphoma Patients Cost-Effective in the US?

Gregory F Guzauskas, MSPH, PhD, Anthony Masaquel, MPH, PhD, Per-Olof Thuresson, MSc, Jia Li, PhD, Carolina M Reyes, PhD, David Veenstra, PharmD, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5603.
https://doi.org/10.1182/blood.V130.Suppl_1.5603.5603
Published: 2017
Journal Articles

What Do Patients Prioritize in Selecting Chronic Lymphocytic Leukemia (CLL) Treatments?

Carol Mansfield, PhD, Anthony Masaquel, MPH, PhD, Jessie Sutphin, Elisa S Weiss, PhD, Meghan E. Gutierrez, Jennifer Wilson, Jia Li, PhD, Carolina Reyes, PhD
Journal: Blood
Blood (2016) 128 (22): 1239.
https://doi.org/10.1182/blood.V128.22.1239.1239
Published: 2016
Journal Articles

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Harbors Frequent Splicesosome Mutations That Cause Aberrant RNA Splicing Affecting Genes Critical in pDC Differentiation and Function

Katsuhiro Togami, MD PhD, Vikas Madan, PhD, Jia Li, PhD, Alexandra-Chloe Villani, PhD, Siranush Sarkizova, BS, Mahmoud Ghandi, PhD, Kevin Buczkowski, BS, Yvonne Li, PhD, Sabeha Biichle, BS, Fanny Angelot-Delettre, PhD, Michael Seiler, PhD, Silvia Buonamici, PhD, Justin Taylor, MD, Omar Abdel-Wahab, MD, Peter S Hammerman, MD PhD, Nir Hacohen, PhD, Henry Yang, PhD, Francine Garnache-Ottou, PhD, H. Phillip Koeffler, MD PhD, Andrew A. Lane, MD PhD
Journal: Blood
Blood (2016) 128 (22): 738.
https://doi.org/10.1182/blood.V128.22.738.738
Published: 2016